Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Personalized Management of Type 2 Diabetes Using AI-Guided (GenAIS TM) Dietary Supplementation [NA]

View source ↗

Summary

Clinical trial evaluating AI-guided GenAIS dietary supplementation for Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GenAIS TM

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Diabetes | NA | Status: COMPLETED